The New Jersey Economic Development Authority (NJEDA) is thrilled to present “Navigating the Current Life Sciences Investing Environment” at Princeton Innovation Center BioLabs on Tuesday, July 25, from 5–7 p.m. This event will feature an engaging discussion from a distinguished panel of investors.
Kara Moore, sector lead for life sciences, will provide a brief overview of NJEDA programs to support this ecosystem. Lexie Demirali, senior venture officer for venture programs, will proceed to moderate an expert panel of investors who have their hands on the pulse of fundraising in life sciences as we get an insight into deals, trends, and challenges for 2023. This is an opportunity to receive perspective into the future direction and anticipated changes in life sciences and healthcare industries.
Key Talking Points:
• Fundraising Strategies: Discover effective techniques for attracting venture capital investment and capturing investors’ attention.
• Investor Perspectives: Gain a deeper understanding of the investor’s mindset, criteria, and decision-making processes.
• Challenges and Solutions: Overcome common fundraising challenges and learn how to navigate due diligence and valuation negotiations.
Don’t miss this unique chance to learn from investors, gain insider knowledge, and network opportunities. Whether you’re a startup founder or an aspiring entrepreneur, reserve your spot now for this must-attend event. NJEDA appreciates the support of BioNJ and Princeton Innovation Center BioLabs to strengthen the New Jersey life sciences ecosystem.
Panelist: Jim Gale, Founding Partner and Managing Director, Signet Healthcare Partners
Panelist: Squire Servance, Founder and Managing Partner, Syridex Bio
Panelist: TBD
Moderator: Lexie Demirali, Senior Venture Officer, Venture Programs, NJEDA